MondegarAI
SUVRETTA CAPITAL MANAGEMENT, LLC

Q3 2024 · 13F-HR

SUVRETTA CAPITAL MANAGEMENT, LLCholdings as filed

Filed 2024-11-14 · accession 0001172661-24-004788

$3.13B
Reported value
98
Positions
2024-09-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
78462F103SPYSPDR S&P 500 ETF TR$315.6M10.1%550,000PUTSOLE
G1110E107BHVNBIOHAVEN LTD$259.8M8.31%5,199,219CommonSOLE
50127T109KURAKURA ONCOLOGY INC$149.5M4.78%7,652,782CommonSOLE
457669307INSMINSMED INC$119.4M3.82%1,635,709CommonSOLE
46116X101ITCIEURINTRA-CELLULAR THERAPIES INC$105.3M3.37%1,439,026CommonSOLE
03969K108ARQTARCUTIS BIOTHERAPEUTICS INC$99.7M3.19%10,721,511CommonSOLE
30303M102METAMETA PLATFORMS INC$96.4M3.09%168,488CommonSOLE
91324P102UNHUNITEDHEALTH GROUP INC$85.9M2.75%146,845CommonSOLE
08205P209BNTCBENITEC BIOPHARMA INC$81.1M2.60%8,829,053CommonSOLE
037833100AAPLAPPLE INC$78.3M2.51%336,147CommonSOLE
023135106AMZNAMAZON COM INC$65.6M2.10%352,069CommonSOLE
90400D108RAREULTRAGENYX PHARMACEUTICAL IN$64.0M2.05%1,151,314CommonSOLE
874039100TSMTAIWAN SEMICONDUCTOR MFG LTD$60.6M1.94%348,742CommonSOLE
282559103ETNBGBP89BIO INC$59.1M1.89%7,991,644CommonSOLE
03769M106APOAPOLLO GLOBAL MGMT INC$58.1M1.86%465,050CommonSOLE
03940C100ACLXGBXARCELLX INC$57.6M1.84%689,950CommonSOLE
007903107AMDADVANCED MICRO DEVICES INC$56.9M1.82%346,575CommonSOLE
855244109SBUXSTARBUCKS CORP$53.6M1.72%550,309CommonSOLE
38141G104GSGOLDMAN SACHS GROUP INC$53.6M1.72%108,308CommonSOLE
G7709Q104RPRXROYALTY PHARMA PLC$52.8M1.69%1,866,361CommonSOLE
88160R101TSLATESLA INC$50.7M1.62%193,842CommonSOLE
00206R102TAT&T INC$50.3M1.61%2,285,336CommonSOLE
G25508105CRHCRH PLC$50.0M1.60%538,894CommonSOLE
483497103KALVKALVISTA PHARMACEUTICALS INC$48.8M1.56%4,212,005CommonSOLE
31488V107FERGFERGUSON ENTERPRISES INC$44.7M1.43%225,210CommonSOLE
04272N102AVBPARRIVENT BIOPHARMA INC$43.4M1.39%1,845,162CommonSOLE
191216100KOCOCA COLA CO$42.3M1.35%588,912CommonSOLE
594918104MSFTMICROSOFT CORP$41.5M1.33%96,526CommonSOLE
30233G209EYPTEYEPOINT PHARMACEUTICALS INC$41.4M1.32%5,175,823CommonSOLE
68389X105ORCLORACLE CORP$40.4M1.29%237,094CommonSOLE
369604301GEGE AEROSPACE$37.8M1.21%200,662CommonSOLE
29479A108ERASERASCA INC$37.6M1.20%13,768,039CommonSOLE
14040H105COFCAPITAL ONE FINL CORP$35.3M1.13%235,600CommonSOLE
22788C105CRWDCROWDSTRIKE HLDGS INC$34.3M1.10%122,155CommonSOLE
92343V104VZVERIZON COMMUNICATIONS INC$34.1M1.09%758,674CommonSOLE
21217B100CTNMCONTINEUM THERAPEUTICS INC$32.9M1.05%1,720,000CommonSOLE
580135101MCDMCDONALDS CORP$31.6M1.01%103,638CommonSOLE
09077V100BIOABIOAGE LABS INC$30.3M0.97%1,455,000CommonSOLE
49271V100KDPKEURIG DR PEPPER INC$26.4M0.84%703,095CommonSOLE
869367102SUTRO BIOPHARMA INC$24.9M0.80%7,187,495CommonSOLE
517834107LVSLAS VEGAS SANDS CORP$24.4M0.78%484,110CommonSOLE
G7S53R104PROKIDNEY CORP$23.7M0.76%12,341,266CommonSOLE
458140100INTCINTEL CORP$23.5M0.75%1,000,000CALLSOLE
00289Y206ABEOABEONA THERAPEUTICS INC$23.3M0.75%3,685,503CommonSOLE
478160104JNJJOHNSON & JOHNSON$22.4M0.72%138,447CommonSOLE
101137107BSXBOSTON SCIENTIFIC CORP$21.1M0.67%251,689CommonSOLE
72352L106PINSPINTEREST INC$19.9M0.64%615,911CommonSOLE
G9TY5A101ZURAZURA BIO LTD$19.7M0.63%4,860,939CommonSOLE
713317105PEPGPEPGEN INC$14.2M0.45%1,660,932CommonSOLE
61225M102GLUEMONTE ROSA THERAPEUTICS INC$14.1M0.45%2,659,000CommonSOLE
983134107WYNNWYNN RESORTS LTD$12.8M0.41%133,000CommonSOLE
03969F109RCUSARCUS BIOSCIENCES INC$10.1M0.32%663,603CommonSOLE
80105N105SNYSANOFI$10.1M0.32%174,901CommonSOLE
810648105SCPHSCPHARMACEUTICALS INC$9.3M0.30%2,049,009CommonSOLE
56854Q200MRNS*MARINUS PHARMACEUTICALS INC$8.9M0.29%5,073,913CommonSOLE
N44821101IFRXINFLARX NV$8.8M0.28%5,733,910CommonSOLE
500767306KWEBKRANESHARES TRUST$7.8M0.25%230,000CommonSOLE
464287184FXIISHARES TR$7.7M0.25%242,500CommonSOLE
36266G107GEHCGE HEALTHCARE TECHNOLOGIES I$7.0M0.23%75,000CommonSOLE
30063P105EXKEXACT SCIENCES CORP$6.4M0.21%94,100CommonSOLE
09062X103BIIBBIOGEN INC$5.8M0.19%29,946CommonSOLE
49372L100KEZAR LIFE SCIENCES INC$5.5M0.18%7,167,591CommonSOLE
881624209TEVATEVA PHARMACEUTICAL INDS LTD$4.8M0.15%268,100CommonSOLE
235851102DHRDANAHER CORPORATION$4.6M0.15%16,427CommonSOLE
883556102TMOTHERMO FISHER SCIENTIFIC INC$4.5M0.14%7,260CommonSOLE
359616109FULCFULCRUM THERAPEUTICS INC$4.2M0.14%1,182,791CommonSOLE
49177J102KVUEKENVUE INC$4.0M0.13%171,596CommonSOLE
002824100ABTABBOTT LABS$3.8M0.12%33,520CommonSOLE
02043Q107ALNYALNYLAM PHARMACEUTICALS INC$3.8M0.12%13,824CommonSOLE
28414H103ELANELANCO ANIMAL HEALTH INC$3.7M0.12%253,600CommonSOLE
592688105MTDMETTLER TOLEDO INTERNATIONAL$2.9M0.09%1,964CommonSOLE
03073E105CORCENCORA INC$2.8M0.09%12,488CommonSOLE
46120E602ISRGINTUITIVE SURGICAL INC$2.6M0.08%5,200CommonSOLE
252131107DXCMDEXCOM INC$2.1M0.07%31,680CommonSOLE
60853G106MOLNMOLECULAR PARTNERS AG$2.0M0.07%400,000CommonSOLE
05352A100AVTRAVANTOR INC$1.9M0.06%71,850CommonSOLE
46266C105IQVIQVIA HLDGS INC$1.7M0.05%7,175CommonSOLE
863667101SYKSTRYKER CORPORATION$1.6M0.05%4,360CommonSOLE
G5960L103MDTMEDTRONIC PLC$1.6M0.05%17,460CommonSOLE
36315X101LKFTGALAPAGOS NV$1.4M0.04%47,200CommonSOLE
40412C101HCAHCA HEALTHCARE INC$1.3M0.04%3,190CommonSOLE
632307104NTRANATERA INC$1.3M0.04%10,100CommonSOLE
452327109ILMNILLUMINA INC$1.1M0.04%8,730CommonSOLE
941848103WATWATERS CORP$1.1M0.04%3,150CommonSOLE
152309100CNTACENTESSA PHARMACEUTICALS PLC$1.1M0.04%70,000CommonSOLE
126650100CVSCVS HEALTH CORP$1.1M0.03%17,170CommonSOLE
58155Q103MCKMCKESSON CORP$904,7890.03%1,830CommonSOLE
69380Q107PACSPACS GROUP INC$799,4000.03%20,000CommonSOLE
00846U101AAGILENT TECHNOLOGIES INC$740,9150.02%4,990CommonSOLE
28176E108EWEDWARDS LIFESCIENCES CORP$732,4890.02%11,100CommonSOLE
92338C103VLTOVERALTO CORP$612,4340.02%5,475CommonSOLE
761152107RMDRESMED INC$583,4470.02%2,390CommonSOLE
462222100IONSIONIS PHARMACEUTICALS INC$432,6480.01%10,800CommonSOLE
G8473T100STESTERIS PLC$371,0860.01%1,530CommonSOLE
98956P102ZBHZIMMER BIOMET HOLDINGS INC$351,9170.01%3,260CommonSOLE
071813109BAXBAXTER INTL INC$302,6210.01%7,970CommonSOLE
016255101ALGNALIGN TECHNOLOGY INC$279,7520.01%1,100CommonSOLE
09073M104TECHBIO-TECHNE CORP$207,8180.01%2,600CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.